HD-OPM Archive
Topics › Brain health & dementia

pTau217 blood test makes early Alzheimer's detection possible, says Science Perspective

Louis Nervegna · May 20, 2026 · ♥ 11 reactions · 0 comments · original Facebook post
Brain health & dementiaRisk assessment & lab tests
AI summary & key facts

Louis shares a Science Perspective on pTau217, a blood biomarker that detects early Alzheimer's pathology non-invasively, potentially years before symptoms.

The pTau217 blood test is rapidly transforming Alzheimer’s care.

It makes early detection possible, so that treatment can be started early, even before symptoms become noticeable.

#ptau217HD #alzheimersHD

Research cited

Shared from Science · original post

In a new Science Perspective, researchers highlight a newly developed blood-based biomarker, pTau217, which allows detection of early pathological changes associated with Alzheimer’s disease without invasive procedures.

Learn more:

Paper · Science · 2026Tracking the turning point in Alzheimer’s diseaseA blood biomarker reveals the mechanistic shift from amyloid to tau pathologyscience.orgNo photo description available.
← newer: Lowering triglycerides alone does not shrink plaque: olezarsolder: ARPA-H PROSPR program ($144M) funds first phase 3 aging tria →